{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:01Z","timestamp":1761514081112},"reference-count":32,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Armed Forces Health Surveillance Center\u2019s Global Emerging Infections Surveillance Division"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.059","type":"journal-article","created":{"date-parts":[[2017,10,8]],"date-time":"2017-10-08T12:02:00Z","timestamp":1507464120000},"page":"6103-6111","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals"],"prefix":"10.1016","volume":"35","author":[{"given":"Peifang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy F.","family":"Crum-Cianflone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Defang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Agan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahaniyat","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.059_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03256397","article-title":"The influenza pandemic of 2009: lessons and implications","volume":"15","author":"Shapshak","year":"2011","journal-title":"Mol. Diagnosis Therapy"},{"key":"10.1016\/j.vaccine.2017.09.059_b0010","first-page":"1","article-title":"Structural and antigenic variance between novel influenza A\/H1N1\/2009 and influenza A\/H1N1\/2008 viruses","volume":"4","author":"Saxena","year":"2010","journal-title":"J Infect Dev Countries"},{"key":"10.1016\/j.vaccine.2017.09.059_b0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.09.059_b0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2010.12.116","article-title":"Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial","volume":"29","author":"Plennevaux","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.059_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2009.1911","article-title":"Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial","volume":"303","author":"Nolan","year":"2010","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2017.09.059_b0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/infdis\/jis360","article-title":"Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults","volume":"206","author":"Flynn","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.059_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-200060010-00004","article-title":"Humoral immune response to influenza vaccination in patients from high risk groups","volume":"60","author":"Brydak","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2017.09.059_b0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood-2011-12-396648","article-title":"Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1\/09 vaccine","volume":"120","author":"Pallikkuth","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2017.09.059_b0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.transproceed.2013.11.063","article-title":"Comparison of the immunogenicity of a monovalent influenza A\/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations","volume":"46","author":"Watcharananan","year":"2014","journal-title":"Transpl Proc"},{"key":"10.1016\/j.vaccine.2017.09.059_b0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1310\/hct1404-175","article-title":"Immune response after a single dose of the 2010\/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls","volume":"14","author":"Bickel","year":"2013","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.vaccine.2017.09.059_b0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cid\/ciq019","article-title":"Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults","volume":"52","author":"Crum-Cianflone","year":"2011","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.09.059_b0060","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.vaccine.2011.02.040","article-title":"Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults","volume":"29","author":"Crum-Cianflone","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.059_b0065","first-page":"167","article-title":"Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients","volume":"39","author":"Yamanaka","year":"2005","journal-title":"J Acq Immune Deficiency Syndrom"},{"key":"10.1016\/j.vaccine.2017.09.059_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/aid.2005.21.407","article-title":"Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients","volume":"21","author":"Ranieri","year":"2005","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.vaccine.2017.09.059_b0075","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/320747","article-title":"Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City","volume":"32","author":"Fine","year":"2001","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.09.059_b0080","doi-asserted-by":"crossref","first-page":"e16496","DOI":"10.1371\/journal.pone.0016496","article-title":"Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination","volume":"6","author":"Soonawala","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.09.059_b0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/INF.0b013e3181e2872f","article-title":"The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination","volume":"29","author":"Ambrose","year":"2010","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.059_b0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.059_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2249.2011.04550.x","article-title":"Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults","volume":"168","author":"Crum-Cianflone","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.09.059_b0100","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.059_b0105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.059_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/CVI.00336-07","article-title":"Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine","volume":"15","author":"Clutterbuck","year":"2008","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.09.059_b0115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.00387-05","article-title":"Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay","volume":"13","author":"Samri","year":"2006","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.09.059_b0120","doi-asserted-by":"crossref","first-page":"e14330","DOI":"10.1371\/journal.pone.0014330","article-title":"Equivalence of ELISpot assays demonstrated between major HIV network laboratories","volume":"5","author":"Gill","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.09.059_b0125","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.1007270107","article-title":"Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses","volume":"107","author":"Gras","year":"2010","journal-title":"Proc National Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.09.059_b0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/infdis\/jis664","article-title":"Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine","volume":"207","author":"He","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.059_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nature Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.09.059_b0140","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1128\/JVI.01439-12","article-title":"Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease","volume":"86","author":"Vincent","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.059_b0145","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.059_b0150","doi-asserted-by":"crossref","first-page":"e36773","DOI":"10.1371\/journal.pone.0036773","article-title":"Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals","volume":"7","author":"Lagler","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.09.059_b0155","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1177\/1060028013507901","article-title":"Booster and higher antigen doses of inactivated influenza vaccine in HIV-infected patients","volume":"47","author":"Johnston","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2017.09.059_b0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1519690113","article-title":"Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood","author":"Nakaya","year":"2016","journal-title":"Proc National Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:07:52Z","timestamp":1535328472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17313075"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}